Drug Type Biological products |
Synonyms Ancer20, SSM, 结核杆菌热水提取物 + [5] |
Target- |
Action modulators |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (28 Jun 1991), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Leukopenia | Japan | 28 Jun 1991 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Cervical Carcinoma | Phase 3 | United States | 01 Dec 2014 | |
Locally Advanced Cervical Carcinoma | Phase 3 | Japan | 01 Dec 2014 | |
Locally Advanced Cervical Carcinoma | Phase 3 | Malaysia | 01 Dec 2014 | |
Locally Advanced Cervical Carcinoma | Phase 3 | Singapore | 01 Dec 2014 | |
Locally Advanced Cervical Carcinoma | Phase 3 | Taiwan Province | 01 Dec 2014 | |
Locally Advanced Cervical Carcinoma | Phase 3 | Thailand | 01 Dec 2014 | |
Locally Advanced Cervical Carcinoma | Phase 3 | Vietnam | 01 Dec 2014 | |
HIV Infections | Phase 1 | United States | 31 Aug 2001 |
Phase 3 | 249 | zlnrtbwbvv(ojudaueraf) = cbmnyhsqbs nukrmrvymh (eqfurpsusr, 66.4 - 82.8) | Positive | 20 May 2013 | |||
Placebo | zlnrtbwbvv(ojudaueraf) = wyevltdkzo nukrmrvymh (eqfurpsusr, 56.2 - 73.8) |